Biovail Announces Third-Quarter 2009 Earnings Release, Conference-Call Details

• Press Release
• Source: Biovail Corporation
• On 10:00 am EDT, Friday October 23, 2009

TORONTO--(BUSINESS WIRE)--Biovail Corporation (NYSE:BVF - News) (TSX:BVF - News) today announced that it will host a conference call and webcast on Thursday, November 5, 2009 at 8:30a.m. for Company executives to discuss third-quarter 2009 financial and operational results.

Related Quotes

Symbol	Price	Change
BVF	14.34	0.00

{"s" : "bvf,bvf.to","k" : "c10,l10,p20,t10","o" : "","j" : ""}

Following the discussion, Biovail executives will address inquiries from investment analysts.

A live webcast of this call will be available through the Investor Relations section of Biovail’s website at www.biovail.com. To access the call live, please dial 416-340-8427 (Toronto and International callers) and 1-866-225-2055 (U.S. and Canada). Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays.

A replay of the conference call will be available until 7:00p.m. ET on Thursday, November 12, 2009 by dialing 416-695-5800 (Toronto and International callers) and 1-800-408-3053 (U.S. and Canada), using access code: 2777843#.

About Biovail Corporation

Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets. For more information about Biovail, visit the Company’s Web site at www.biovail.com.

For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to ir@biovail.com.

Biovail Corporation
Nelson F. Isabel, (905) 286-3000
Vice-President, Investor Relations & Corporate Communications